-Search query
-Search result
Showing all 32 items for (author: franzetti & b)

EMDB-53317: 
CryoEM structure of the tetrahedral M42 aminopeptidase from M. jannaschii
Method: single particle / : Atalah J, Basbous H, Girard E, Effantin E, Schoehn G, Franzetti B

PDB-9qr6: 
CryoEM structure of the tetrahedral M42 aminopeptidase from M. jannaschii
Method: single particle / : Atalah J, Basbous H, Girard E, Effantin E, Schoehn G, Franzetti B

EMDB-29530: 
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

EMDB-29531: 
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

EMDB-40240: 
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

PDB-8fxb: 
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

PDB-8fxc: 
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

PDB-8s9g: 
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

EMDB-27177: 
sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein
Method: single particle / : Abernathy ME, Barnes CO

PDB-8d48: 
sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein
Method: single particle / : Abernathy ME, Barnes CO

EMDB-24236: 
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D

EMDB-24237: 
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20)
Method: single particle / : McCallum M, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

PDB-7n8h: 
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
Method: single particle / : McCallum M, Veesler D, Seattle Structural Genomics Center for Infectious Disease (SSGCID)

PDB-7n8i: 
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20)
Method: single particle / : McCallum M, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D

EMDB-22491: 
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Snell G, Veesler D

EMDB-22492: 
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Snell G, Veesler D

EMDB-22494: 
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Snell G, Veesler D

EMDB-22497: 
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Snell G, Veesler D

EMDB-22506: 
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Snell G, Veesler D

EMDB-22507: 
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (two receptor-binding domains open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D

EMDB-22508: 
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (three receptor-binding domains open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D

EMDB-22512: 
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
Method: single particle / : Walls AC, Park YJ, Tortorici MA, Czudnochowski N, Snell G, Veesler D

EMDB-22516: 
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D

EMDB-22517: 
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D

PDB-7jv2: 
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D

PDB-7jv4: 
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D

PDB-7jv6: 
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D

PDB-7jva: 
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D

PDB-7jvc: 
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Tortorici MA, Walls AC, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D

PDB-7jw0: 
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
Method: single particle / : Walls AC, Park YJ, Tortorici MA, Czudnochowski N, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Snell G, Veesler D

EMDB-1188: 
An archaeal peptidase assembles into two different quaternary structures: A tetrahedron and a giant octahedron.
Method: single particle / : Schoehn G, Vellieux FM, Asuncion Dura M, Receveur-Brechot V, Fabry CM, Ruigrok RW, Ebel C, Roussel A, Franzetti B

EMDB-1189: 
An archaeal peptidase assembles into two different quaternary structures: A tetrahedron and a giant octahedron.
Method: single particle / : Schoehn G, Vellieux FM, Asuncion Dura M, Receveur-Brechot V, Fabry CM, Ruigrok RW, Ebel C, Roussel A, Franzetti B
Movie
Controller
Structure viewers
About EMN search



wwPDB to switch to version 3 of the EMDB data model
